**Question:** Good prognosis factors of ALL are all except –

A. Leukocyte count 50 years
D. Platelet count <50,000/mm³ **Core Concept:** Acute Lymphoblastic Leukemia (ALL) is a type of blood cancer characterized by rapid proliferation of lymphoid precursor cells in the bone marrow and blood. Good prognosis factors and poor prognosis factors help oncologists to assess the disease severity and tailor treatment plans accordingly. **Why the Correct Answer is Right:** Good prognosis factors in ALL aim to identify patients with a better response to treatment and a higher likelihood of achieving remission and long-term survival. The correct answer (A, B, C, D) represents poor prognosis factors that indicate a higher risk of treatment failure or disease progression. - Leukocyte count 50 years (Option C): Increased age is often associated with a higher prevalence of co-morbidities and decreased immune function, which can have a negative impact on treatment response and survival in ALL patients.
- Platelet count <50,000/mm³ (Option D): Similar to leukocyte count, a low platelet count indicates early disease presentation and a better prognosis. However, having a platelet count above this threshold indicates a more advanced disease stage and poorer prognosis. **Why Each Wrong Option is Incorrect:** 1. A high leukocyte count (Option A): A low leukocyte count indicates early disease presentation and a better prognosis, while a high count is associated with a more advanced disease stage and poorer prognosis. 2. Applying a prognostic score (Option B): A prognostic score can help guide treatment decisions, but having a score itself does not negate being a poor prognosis factor. 3. Being older than 50 years (Option C): Increased age is often associated with a higher prevalence of comorbidities and decreased immune function, which can negatively impact treatment response and survival in ALL patients. 4. A low platelet count (Option D): Similar to leukocyte count, a low platelet count indicates early disease presentation and better prognosis. However, having a platelet count above this threshold indicates a more advanced disease stage and poorer prognosis. **Clinical Pearl:** The importance of considering both high and low counts for leukocytes, platelets, and age when assessing the prognosis in ALL patients is crucial for accurate treatment planning and patient management. **Core Concept:** When assessing the prognosis in Acute Lymphoblastic Leukemia (ALL), oncologists consider various factors such as: 1. **Leukocyte count:** Leuk